Corcept Therapeutics Inc. shares fell after US regulators rejected the company’s drug to treat a form of high blood pressure.
www.bloomberg.com
#Corcept #Shares #Sink #FDA #Rejects #Drug #Treat #Hypertension
Corcept Shares Sink After FDA Rejects Drug to Treat Hypertension
